Bradley E, Webb TI, Hollywood MA, Sergeant GP, McHale NG, Thornbury KD. The cardiac sodium current Nav1.5 is functionally expressed in rabbit bronchial smooth muscle cells. Am J Physiol Cell Physiol 305: C427-C435, 2013. First published June 19, 2013 doi:10.1152/ajpcell.00034.2013.-A collagenase-proteinase mixture was used to isolate airway smooth muscle cells (ASMC) from rabbit bronchi, and membrane currents were recorded using the whole cell patch-clamp technique. Stepping from Ϫ100 mV to a test potential of Ϫ40 mV evoked a fast voltage-dependent Na ϩ current, sometimes with an amplitude of several nanoamperes. The current disappeared within 15 min of exposure to papain ϩ DTT (n ϭ 6). Comparison of the current in ASMC with current mediated by NaV1.5 ␣-subunits expressed in human embryonic kidney cells revealed similar voltage dependences of activation (V1/2 ϭ Ϫ42 mV for NaV1.5) and sensitivities to TTX (IC50 ϭ 1.1 and 1.2 M for ASMC and NaV1.5, respectively). The current in ASMC was also blocked by lidocaine (IC50 ϭ 160 M). Although veratridine, an agonist of voltage-gated Na ϩ channels, reduced the peak current by 33%, it slowed inactivation, resulting in a fourfold increase in sustained current (measured at 25 ms after onset). In current-clamp mode, veratridine prolonged evoked action potentials from 37 Ϯ 9 to 1,053 Ϯ 410 ms (n ϭ 8). Primers for NaV1.2-1.9 were used to amplify mRNA from groups of ϳ20 isolated ASMC and from whole bronchial tissue by RT-PCR. Transcripts for NaV1.2, NaV1.3, and NaV1.5-1.9 were detected in whole tissue, but only NaV1.2 and NaV1.5 were detected in single cells. We conclude that freshly dispersed rabbit ASMC express a fast voltage-gated Na ϩ current that is mediated mainly by the NaV1.5 subtype. sodium current; Nav1.5; airway smooth muscle; patch clamp VOLTAGE-GATED SODIUM CHANNELS (VGSC) are normally associated with excitable cells, such as neurons and skeletal and cardiac myocytes, where they are responsible for the initiation and propagation of the action potential. They are classified according to their pore-forming ␣-subunits, of which there are nine known subtypes, designated Na V 1.1-1.9, encoded by the SCN gene family (SCN1A-5A and SCN8A-11A) (5). Perhaps surprisingly, VGSC have also been found in some nonexcitable cell types, including Schwann cells, cultured fibroblasts, cultured vascular endothelial cells, and metastatic cancer cells, although their role in these cells is poorly understood (1, 4, 6, 8, 11, 12, 19, 26) . In freshly dispersed smooth muscle cells, VGSC were previously regarded as a rarity, but evidence for their existence in this cell type has been gradually accumulating. In phasic tissues, such as uterine, lymphatic, vas deferens, portal vein, and gastrointestinal smooth muscle, they may play a part in the generation and/or propagation of spontaneous electrical activity underlying myogenic contractions (14, 15, 29, 31, 38) . However, they have also been found in a variety of tonic arterial smooth muscles (7, 9, 21, 27) , although mostly only in cultured cells, suggesting that they are indicative of an altered phenotype (9, 27). However, this idea has been challenged by the finding that Na ϩ currents were found in freshly dispersed mesenteric artery cells, so long as precautions, such as avoidance of the use of papain, are taken with the dispersal method (3). In airway smooth muscle, a direct comparison was made between cultured and freshly dispersed human bronchial smooth muscle cells, where Na ϩ current was found only in the cultured cells (32). The presence of this current in cultured human bronchial myocytes, probably due to expression of Na V 1.7, was later confirmed by two other studies (18, 24) .
VOLTAGE-GATED SODIUM CHANNELS (VGSC) are normally associated with excitable cells, such as neurons and skeletal and cardiac myocytes, where they are responsible for the initiation and propagation of the action potential. They are classified according to their pore-forming ␣-subunits, of which there are nine known subtypes, designated Na V 1.1-1.9, encoded by the SCN gene family (SCN1A-5A and SCN8A-11A) (5) . Perhaps surprisingly, VGSC have also been found in some nonexcitable cell types, including Schwann cells, cultured fibroblasts, cultured vascular endothelial cells, and metastatic cancer cells, although their role in these cells is poorly understood (1, 4, 6, 8, 11, 12, 19, 26) . In freshly dispersed smooth muscle cells, VGSC were previously regarded as a rarity, but evidence for their existence in this cell type has been gradually accumulating. In phasic tissues, such as uterine, lymphatic, vas deferens, portal vein, and gastrointestinal smooth muscle, they may play a part in the generation and/or propagation of spontaneous electrical activity underlying myogenic contractions (14, 15, 29, 31, 38) . However, they have also been found in a variety of tonic arterial smooth muscles (7, 9, 21, 27) , although mostly only in cultured cells, suggesting that they are indicative of an altered phenotype (9, 27) . However, this idea has been challenged by the finding that Na ϩ currents were found in freshly dispersed mesenteric artery cells, so long as precautions, such as avoidance of the use of papain, are taken with the dispersal method (3) . In airway smooth muscle, a direct comparison was made between cultured and freshly dispersed human bronchial smooth muscle cells, where Na ϩ current was found only in the cultured cells (32) . The presence of this current in cultured human bronchial myocytes, probably due to expression of Na V 1.7, was later confirmed by two other studies (18, 24) .
In the present study, we set out to reexamine the membrane currents in rabbit smooth muscle cells freshly dispersed from small bronchi. We used a short digestion with collagenase and avoided use of papain to minimize digestion of ion channel proteins. To our surprise, we found a large VGSC in the majority of myocytes examined and now report its biophysical and pharmacological characteristics, as well as its likely molecular identity.
METHODS
Tissue dissection and cell isolation. All procedures were carried out in accordance with current European Union legislation and with approval of the Dundalk Institute of Technology Animal Use and Care Committee. Male and female New Zealand white rabbits (16 -20 wk old) were humanely killed with an intravenous injection of pentobarbitone, and the lungs were removed and placed in oxygenated Krebs solution. The bronchial tree was exposed by sharp dissection under a microscope to remove surrounding blood vessels and lung tissue (Fig. 1A) . The secondary and tertiary bronchi were removed and cut into small pieces and placed in Hanks' Ca 2ϩ -free solution (see below). Single airway smooth muscle cells (ASMC) were isolated using a collagenase-proteinase mixture consisting of (per 5 ml of Hanks' Ca 2ϩ -free solution) 15 mg of collagenase (type IA, Sigma), 1 mg of proteinase (type XXIV, Sigma), 10 mg of BSA (Sigma), and 10 mg of trypsin inhibitor (Sigma) for ϳ5 min at 37°C. They were then placed in Hanks' Ca 2ϩ -free solution and stirred for 10 -20 min to release single relaxed smooth muscle cells, which were plated in petri dishes containing Hanks' Ca 2ϩ -free solution (with Ca 2ϩ added to a concentration of 100 M) and stored at 4°C for use within 6 h.
Human embryonic kidney cells. A stable cell line expressing human Na V1.5 in human embryonic kidney (HEK 293) cells was purchased from CreaCell and cultured using the recommended protocols. Briefly, cells were cultured at 37°C using DMEM (Invitrogen) containing 10% fetal bovine serum, glutamine, penicillin-streptomycin, and 1.2 mg/ml G418 in a humidified incubator under 5% CO 2.
Patch-clamp recording. Currents were recorded as previously described using the ruptured-patch configuration of the whole cell patch-clamp technique (14) . Pipettes were pulled from borosilicate glass capillary tubing (1.5 mm OD, 1.17 mm ID; Clark Medical Instruments) to a tip of diameter ϳ1-1.5 m and resistance of 2-4 M⍀. Voltage-clamp commands were delivered via Axopatch 1D (Axon Instruments) or VE2 patch-clamp (Alembic Instruments) amplifiers interfaced to a computer running pCLAMP software (Axon Instruments). Series resistance and the capacitive surge were electron-ically compensated by 50 -80%. Liquid junction potentials were less than Ϫ3 mV and were uncompensated.
During experiments, the dish containing the cells was superfused with physiological saline solution. In addition, the cell under study was continuously superfused by means of a close delivery system consisting of a pipette (200-m tip diameter) placed ϳ300 m away. This could be switched, with a dead-space time of Ͻ5 s, to a solution containing a drug. All experiments were carried out at 37°C.
RT-PCR.
RT-PCR was performed on isolated smooth muscle cells and on dissected samples of whole tissue [rabbit airway, brain, and dorsal root ganglion (DRG)]. Twenty freshly dispersed ASMC were collected using a micropipette and then flash-frozen in liquid N2. RNA was subsequently isolated from ASMC using the RNeasy Micro kit (Qiagen). Dissected tissue samples were cut into 3-mm 3 pieces and stored in RNAlater (Qiagen) prior to processing. RNA was isolated from these tissue samples using the RNeasy Mini kit (Qiagen). All RNA samples were treated with DNase and then stored at Ϫ80°C for later use. RT-PCR was performed using the SuperScript III One-Step system (Invitrogen) in conjunction with forward and reverse primers designed to straddle two exons (Table 1) . Reverse transcription was performed for 30 min at 55°C. Then 40 cycles of PCR were performed at an annealing temperature of 55°C. A second seminested PCR on 1:100-diluted aliquots of the RT-PCRs was necessary for visualization of product from isolated cells. For this procedure, Crimson Taq (New England Biolabs) was utilized. NaV1.5 was not detected when reverse transcriptase was omitted from the RT-PCR. Furthermore, DNA sequencing was used to confirm the identity of a purified amplicon of NaV1.5.
Solutions. The forward primer for the Na ϩ channels (except Nav1.8) was designed to straddle the exon 8-exon 9 boundary. The RT-PCR reverse primer for the Na ϩ channels (except Nav1.8) was designed to straddle the exon 9-exon 10 boundary. The seminested PCR reverse primer for the Na ϩ channels (except Nav1.8) was designed to bind within exon 9. Exon 9-derived sequences in these primers are underlined. The equivalent primers for Nav1.8 straddle the exon 10-exon 11 and exon 11-exon 12 boundaries and bind within exon 11, respectively. Exon 11-derived sequences in these primers are underlined. MYH11 is the gene encoding for smooth muscle myosin heavy chain (SMM HC). The forward primer for SMM HC was designed to bind within exon 1. The RT-PCR reverse primer for SMM HC was designed to straddle the exon 4-exon 5 boundary. The seminested PCR reverse primer for SMM HC was designed to bind within exon 2. Exon 4-derived sequences in these primers are underlined. All primers were designed using sequences obtained from the Ensembl database. The transcript IDs for these sequences are as follows: ENSOCUT00000005542, ENSOCUT00000013019, ENSOCUT00000004354, ENSOCUT00000007872, ENSOCUT00000027610, ENSOCUT00000021177, ENSOCUT00000022351, ENSOCUT00000011805, ENSOCUT00000001379, and ENSOCUT00000024704.
Statistics and data analysis. Values are means Ϯ SE; n is number of cells. Statistical comparisons were made using Student's paired t-test, with significance at P Ͻ 0.05. Experiments were usually performed on a minimum of three animals.
Sigmoidal activation curves were fitted with a Boltzmann equation:
where V1/2 is membrane potential at which there was half-maximal activation, K is the slope factor, Vm is the test potential, g is conductance, and gmax is maximal conductance. Conductance (g) was calculated as follows: g ϭ I/(Vm Ϫ ENa), where ENa is the calculated Nernst potential for Na ϩ and I is the current recorded. Inactivation curves were fitted with a similar Boltzmann function:
where I is the current recorded at the test step, Imax is the maximal current recorded, Vc is the conditioning potential (see RESULTS), and K is the slope factor.
Concentration-effect data were fitted with a Hill-Langmuir equation: I/I control ϭ 1/{1 ϩ 10^(log[Drug] Ϫ log IC50)}, where I is the current recorded in the drug, Icontrol is the current in the absence of drug, IC50 is the half-maximal effective concentration, and [Drug] is the concentration variable. In each case, IC50 is stated, followed by the upper and lower 95% confidence limits (presented in parentheses).
RESULTS
When ASMC were voltage-clamped at negative potentials, typically Ϫ100 mV, and stepped to Ϫ40 mV, large transient inward current was evident in Ͼ80% of cells (Fig. 1B ). This current reached its peak in 1-2 ms and rapidly inactivated, with a time constant of 1.3 Ϯ 0.1 ms at Ϫ40 mV (n ϭ 12). If cells were held at more depolarized potentials, typically Ϫ60 mV, and stepped to 0 mV, a slower inward current was also evident. This current was much smaller in amplitude, rapidly ran down under whole cell recording conditions, and was not studied further. We assumed that this was the L-type Ca 2ϩ current, previously described in many previous studies (16) . The fast current seen here was not a Ca 2ϩ current but was almost entirely carried by Na ϩ , as evidenced by a ϳ95% reduction in amplitude when external Na ϩ concentration was reduced from 130 to 13 mM (Fig. 1, B and C) .
Voltage dependence of the fast Na ϩ current. To further investigate the characteristics of the fast Na ϩ current, we studied the current-voltage (I-V) relationship. Cells were held at Ϫ60 mV and then subjected to a step to Ϫ100 mV for 1 s to remove inactivation (see below) followed by a series of test steps to depolarized potentials ranging from Ϫ80 to ϩ60 mV for 100 ms. Figure 2A shows current responses to several such steps. In this cell, the Na ϩ current was extremely large, with a substantial current evident at the Ϫ50-mV step and a peak of Ϫ4,384 pA achieved at Ϫ30 mV. Of seven cells, four achieved currents Ͼ1,000 pA, and the mean peak current was Ϫ1,489 Ϯ 512 pA (n ϭ 7). The mean I-V relationship is shown in Fig. 2B . The current activated at Ϫ60 mV, peaked at Ϫ30 mV, and reversed at ϩ50 mV. As these characteristics (including several others, such as the voltage dependence of inactivation and TTX sensitivity; see below) were reminiscent of the cardiac Na ϩ (Na V 1.5) current, we made a direct comparison with human Na V 1.5 ␣-subunits overexpressed in HEK cells (Figs. 2C and 3D ). In this case, the mean peak current was Ϫ4,390 Ϯ 1,357 pA (n ϭ 8). It also activated negative to Ϫ50 mV and peaked at Ϫ40 mV (Ϫ30 mV in some cells). In this case, reversal of the current was not achieved.
The current was further characterized by its voltage-dependent inactivation properties. Cells were held at a range of conditioning potentials (from Ϫ120 to Ϫ10 mV) for 2 s and then stepped to a test potential of Ϫ40 mV. Selected sweeps from one ASMC are shown in Fig. 3A , where current inactivated over a voltage range of Ϫ110 to Ϫ70 mV. Summary data . C: selected currents from a human embryonic kidney (HEK) cell expressing Nav1.5. Currents were obtained by stepping from Ϫ100 mV to Ϫ50, Ϫ40, Ϫ30, and Ϫ20 mV. D: summary of the I-V relationship for NaV1.5 (n ϭ 8).
for inactivation of the current in ASMC are presented in Fig.  3B . The points were fitted with a Boltzmann function (see METHODS), yielding V 1/2 ϭ Ϫ88 Ϯ 1 mV and K ϭ 7.3 Ϯ 0.6 mV (n ϭ 8). For comparison, the same inactivation protocol was applied to HEK cells expressing Na V 1.5, where inactivation followed a very similar pattern (Fig. 3, C and D) . Fitting of the Na V 1.5 inactivation data points in Fig. 3D yielded V 1/2 ϭ Ϫ85 Ϯ 1 mV and K ϭ 8.5 Ϯ 1.1 mV (n ϭ 14). Activation curves for native current in ASMC and Na V 1.5 in HEK cells are also plotted in Fig. 3 , B and D, respectively. The curves were derived from the I-V data presented in Fig. 2 by plotting normalized conductance (g/g max ) against the test potential (V m ). The data points in Fig. 3 , B and D, were fitted with Boltzmann functions, yielding V 1/2 ϭ Ϫ42 Ϯ 3 mV and K ϭ 4.9 Ϯ 0.8 mV for ASMC (n ϭ 7) and V 1/2 ϭ Ϫ49 Ϯ 1 mV and K ϭ 5.1 Ϯ 1.1 mV for Na V 1.5 (n ϭ 8).
Pharmacology of the fast Na ϩ current. The voltage-dependent characteristics of the fast Na ϩ current in ASMC are consistent with its mediation by Na V 1.5 ␣-subunits. Another way to discriminate between Na V subunits is to examine their sensitivity to blockade with the neurotoxin TTX. We compared the effects of TTX on the native current in ASMC and in HEK cells expressing Na V 1.5 (Fig. 4, A-D) . Current was evoked in cells held at Ϫ100 mV for 2 s and then stepped to Ϫ40 mV for 100 ms and allowed to rest for 10 s at Ϫ60 mV. Examples are shown in Fig. 4A (ASMC) and Fig. 4C (Na V 1.5), where the blocker reduced the current in each case in a concentrationdependent manner, with 50% block at Ͼ1 but Ͻ3 M. Summary data for native current in ASMC and Na V 1.5 are shown in Fig. 4 , B and D, respectively. Fits of the data with the Hill-Langmuir equation yielded IC 50 values of 1.1 M (range 0.9 -1.5 M) for ASMC (n ϭ 8) and 1.2 M (range 0.9 -1.7 M) for Na V 1.5 (n ϭ 4).
The effect of the local anesthetic lidocaine on ASMC was also examined using the same voltage protocol used for TTX. Figure 4E shows that lidocaine caused a concentration-dependent decrease in current amplitude. A summary of the effect in eight cells is shown in Fig. 4F , where a fit of the data with the Hill-Langmuir equation yielded an IC 50 of 160 M (range 101-253 M).
The plant alkaloid veratridine is an agonist of Na V channels that causes persistent openings by preventing inactivation but also reduces channel conductance by 75% (35) . Veratridine reduced the peak current but caused a sustained component of the current to appear (Fig. 5A , voltage protocol as described for TTX experiments). This sustained current was blocked by TTX, consistent with the idea that it was a manifestation of the Na ϩ current described above. Summary data for the effect of veratridine are shown in Fig. 5 , B and C. Although peak current was reduced (Fig. 5B ) from Ϫ535 Ϯ 96 to Ϫ362 Ϯ 77 pA (P Ͻ 0.001, n ϭ 8), the sustained current, measured 25 ms after the onset of the test step, was increased (Fig. 5C ) from Ϫ53 Ϯ 21 to Ϫ203 Ϯ 33 pA (P Ͻ 0.001, n ϭ 8).
Current-clamp experiments. In experiments where the effect of veratridine had been tested on currents under voltage clamp, the patch-clamp amplifier was then switched to current-clamp recording mode to see if veratridine affected action potential duration. Cells were hyperpolarized to Ϫ100 mV by injection of current and then depolarized with a brief (3-7 ms) injection of inward current. A record from the cell that gave the greatest response is shown in Fig. 5D . Action potential duration in the absence of veratridine was 41 ms and increased to 3.4 s in the presence of veratridine. Summary data for 8 cells are presented in Fig. 5E , where the mean action potential duration (measured from onset to 90% repolarization) increased from 37 Ϯ 9 ms (range 12-91 ms) to 1,053 Ϯ 410 ms (range 268 ms-3.4 s, P Ͻ 0.05).
Experiments were also carried out using K ϩ -rich pipette solution (solution 4, see METHODS) to measure firing threshold, action potential peak, action potential duration, and refractory (Ϫ70 to Ϫ110 mV) . B: mean steady-state inactivation curve (OE) for ASMC (n ϭ 8) and activation curve derived from data in Fig. 2B (, n ϭ 7) . Solid lines are fits obtained from the Boltzmann equation. C: selected currents from a HEK cell expressing Nav1.5. Format as in A. D: mean steady-state inactivation curve (OE) for Nav1.5 (n ϭ 14) and activation curve for Nav1.5 in HEK cells derived from data in Fig. 2D (, n ϭ 8) . g/gmax, Normalized conductance.
period. The mean firing threshold was Ϫ37 Ϯ 1 mV, mean peak depolarization was Ϫ11 Ϯ 5 mV, and mean duration at half-maximum amplitude was 27 Ϯ 4 ms (n ϭ 10 events, 4 cells). The refractory period was assessed using a paired stimulus protocol, whereby the paired stimuli were separated by 50, 100, 150, 200, and 250 ms. The example in Fig. 5F shows responses separated by 50, 100, and 150 ms. Little recovery was seen at 50 ms, partial recovery at 100 ms, and complete recovery at 150 ms. At intervals Ͼ150 ms, the recovery was similar to the example at 150 ms (data not shown). In the four cells tested, recovery was complete by 100 ms in one cell and by 150 ms in the other three cells.
Effect of papain on the fast Na ϩ current. We speculated that the digestion procedure might be crucial to the success of observing the fast Na ϩ current in ASMC, as it was previously reported that use of papain ϩ DTT in the dispersal cocktail had a detrimental effect on the survival of Na ϩ channels (3). Papain possesses a single reactive sulfhydryl group, which is essential for its activity. The sulfhydryl group is oxidized in air, inactivating papain, unless the process is reversed by a reducing agent (30) . Consequently, many studies have used DTT to activate papain (3, 32) . We therefore tested the effect of this combination on the fast Na ϩ current in ASMC and, as a control, also tested the effect of DTT alone. The effect on peak current was assessed using the same voltage protocol used for the antagonists above. In cells exposed to DTT alone, there was no tendency for the current to decline with time; indeed, an increase in current was observed over the period of the experiment ( Fig. 6 ; n ϭ 6), similar to an effect of DTT previously reported (33) . In contrast, in cells treated with papain ϩ DTT, the current declined over the period of the experiment ( Fig. 6 ; n ϭ 6), until it disappeared by 15 min.
Transcriptional expression of Na V 1.5 in bronchial tissue and isolated ASMC. Experiments were also performed to determine which mRNA transcripts encoding Na v channel subtypes were present in isolated ASMC and whole bronchial issue. The efficacy of each of the Na ϩ channel primers for Na V 1.2-1.9 was first confirmed using DRG and brain tissue RNA (Fig. 7A) . When the same procedure was repeated with bronchial tissue RNA, most transcripts were still observed. In contrast, when the procedure was carried out with mRNA from isolated ASMC, message was always observed when Na V 1.5-specific primers were used (n ϭ 7) and was detected in six of seven experiments when Na V 1.2-specific primers were used, while the other primers failed to amplify product (Fig. 7B) . The data in Fig. 7C were obtained as a control to show that isolated cells identified as ASMC were positive for smooth muscle myosin heavy chain. A negative control for Na V 1.5 was also performed on bronchial tissue by omission of reverse transcriptase (Fig. 7D) .
DISCUSSION
In this study we have presented evidence for the expression of a large fast voltage-dependent Na ϩ current in freshly dispersed bronchial myocytes from the rabbit. That this current was largely mediated by the Na V 1.5 ␣-subunit, usually associated with ventricular muscle, was suggested by its TTX sensitivity, voltage-dependent kinetics, and the presence of RNA transcripts encoding this channel in isolated ASMC. Na ϩ channel ␣-subunits have been categorized (5) as TTX-sensitive (IC 50 in the nanomolar range, Na V 1.1-1.4 and Na V 1.7), TTXresistant (IC 50 ϭ 40 -60 M, Na V 1.8 and Na V 1.9), or TTXinsensitive (IC 50 ϭ 1-2 M, Na V 1.5). Thus Na V 1.5 is the only subtype known to fall in to the "insensitive" category, which, in effect, means that it has an intermediate sensitivity to TTX compared with the other channels. The TTX IC 50 of the current in ASMC falls comfortably within the range expected for Na V 1.5 and was very similar to the IC 50 found for Na V 1.5 in HEK cells under identical recording conditions (Fig. 4 ). Another feature of the current mediated by Na V 1.5 is that it inactivates over a more negative voltage range than most of the currents mediated by other Na V subtypes (5) . In the present study the native current and the current in Na V 1.5-expressing HEK-293 cells had very similar V 1/2 of inactivation values. These values were also similar to those reported for Na V 1.5, although such results must be interpreted with the caveat that voltage-dependent kinetics may be influenced by expression of ␤-subunits, different expression systems, and different recording conditions (5) . However, the expression of ␤-subunits may be less of a problem than originally anticipated, as ␤ 1 -subunits are endogenously expressed in ASMC and HEK-293 cells (22, 24) . ␤-Subunits are known to produce modest shifts in the voltage-dependent kinetics and to abolish a slow component of inactivation that results in a large persistent current. It is interesting in this respect that, when Na v ␣-subunits are expressed in frog oocytes, the persistent current is present, unless the cells are cotransfected with a ␤ 1 -subunit (22) . In contrast, in HEK-293 cells transfected with Na v ␣-subunits, the endogenous ␤ 1 -subunit is sufficient to suppress the slow component of inactivation (22) . In our experiments, we did not observe significant persistent currents in HEK-293 cells or native ASMC, suggesting that functionally similar ␤-subunits may have been expressed in both cell types.
In RT-PCR experiments, mRNA encoding Na V 1.5 was readily found in all samples of isolated ASMC, thus supporting the view that Na V 1.5 was expressed in these cells. Although there was also evidence for the presence of mRNA encoding Na V 1.2, current mediated by this subunit is highly TTX-sensitive and shows more positive steady-state voltage-dependent kinetics than the current we recorded in ASMC (for Na V 1.2, V 1/2 of inactivation ϭ Ϫ53 and V 1/2 of activation ϭ Ϫ23 mV) (5). Therefore, although we cannot exclude the possibility that Na V 1.2 contributed a little to the whole cell current in ASMC, its influence overall appears to have been minimal.
Evidence has been steadily accumulating that Na ϩ currents are present in more smooth muscle tissues than previously thought, although the Na V 1.5 subtype is uncommon. Most commonly, the Na V 1.7 subtype has been found, especially in vascular tissue, but its functional role remains unclear (18, 21, 29) . Several studies have pointed to the greater tendency for Na ϩ currents to be expressed in cultured than freshly dispersed cells, leading to suggestions that they participate in cell proliferation or migration (9, 27) . Until now, VGSC have been found in cultured, but not freshly isolated, ASMC. In human airway, a direct electrophysiological comparison was made between ionic currents in freshly isolated vs. cultured myocytes, where a highly TTX-sensitive Na ϩ current was found only in the cultured cells (32) . A similar current was also found in two other studies on human cultured airway myocytes, where, in addition to its electrophysiological characteristics, RT-PCR experiments suggested that it was mediated by the Na V 1.7 ␣-subunit and, therefore, differs from the current we . Effect of papain and DTT on Na ϩ current in ASMC. A: current was evoked by stepping from Ϫ100 to Ϫ40 mV. Exposure to DTT failed to decrease the current, while papain ϩ DTT caused the current to run down. B: summary of the effect of DTT alone (, n ϭ 6) or papain ϩ DTT (, n ϭ 6) on the current. Papain ϩ DTT caused the current to run down in 15 min, while DTT alone slightly increased the current.
described here (18, 24) . The authors of these studies suggested that VGSC might be important in airway remodeling in asthma and, interestingly, showed that expression of Na V 1.7 in cultured cells was inhibited by dexamethasone (24) .
The fact that Na V 1.5 and other Na V subunits appear in some tumor cells, where they are not normally present in the parent tissues, supports the remodeling argument. Examples include breast cancer and prostate cancer cell lines, where they are associated with increased metastatic potential (4, 8, 26) . It seems that the presence of the Na ϩ channel contributes to migration and/or invasion, rather than proliferation, in these cells (4, 10) . How Na ϩ channels are involved in these processes is unknown, but various suggestions have been made, including the idea that metastatic cells acquire a "neuronal" phenotype (25) , that a raised intracellular Na ϩ concentration leads to perimembrane acidification favoring the proteolytic activity of secreted cysteine cathepsins (10), or even that nonconductance mechanisms involving Na ϩ channel ␤-subunits may be responsible (26) .
The question naturally arises as to why the VGSC current described in the present study has not been previously observed in the many published accounts of isolated ASMC in the literature. In some cases, suitable voltage protocols have not been used. Thus, unless the holding potential was set substantially negative to Ϫ60 mV, the current will have been fully inactivated before the test pulse. Another problem is that the fast transient nature of the current means that it could sometimes have been masked by, or confused with, a capacitive transient. Sometimes, however, suitable protocols were applied (16, 32) . Using protocols that adequately demonstrated the presence of the current in cultured cells, Snetkov et al. (32) made a specific attempt to look for Na ϩ current in freshly isolated cells. However, they used a 40-min digestion with papain ϩ DTT to isolate fresh cells. In mesenteric artery, an otherwise robust Na ϩ current disappeared if papain ϩ DTT, rather than collagenase, was used for cell dispersal (3). It is possible, therefore, that the digestion procedure damaged Na ϩ channels in the membranes of the freshly isolated cells in the study of Snetkov et al. Our experiments showed that the same concentrations of papain ϩ DTT used by Snetkov et al. almost abolished the current in rabbit ASMC within 15 min (Fig. 6) . We also found a similar effect on the Na V 1.5-mediated current in HEK cells (M. A. Hollywood, unpublished observations). In contrast, when DTT was used alone, we observed a small increase in current, consistent with similar findings for Na V 1.5 in jejunal smooth muscle (33) . Although the experiments of Janssen (16) did not use papain ϩ DTT, they were done using the perforated-patch configuration of the patch clamp. Compared with the whole cell patch method, this technique often suffers from a reduced electrical access between the pipette and cell, hence broadening the capacitance transient and, thus, possibly obscuring a fast Na ϩ current. Janssen also found that it was necessary to apply a high concentration of niflumic acid to block Ca 2ϩ -activated Cl Ϫ currents, which are more prevalent in perforated-patch experiments than in whole cell recordings because of "rundown" in the latter. Since reports indicate that niflumic acid and other fenamates block VGSC in neurons and heart cells (2, 36, 37) , it is likely that niflumic acid would also have reduced any Na ϩ current in canine ASMC. Therefore, although Na ϩ current has not been previously seen in fresh airway myocytes, in many previous studies the experimental conditions were not optimized for its detection.
Another obvious question is whether Na ϩ currents influence the contractile behavior of the airway smooth muscle or, for that matter, any other smooth muscles where they are present. Probably the most clear-cut example of a functional effect on contraction is in lymphatic vessels, where, like the heart, a spatially well-coordinated contraction is required for myogenic pumping of lymph (14) . Lymphatic smooth muscle cells express a prominent TTX-sensitive Na ϩ current that contributes to their action potential and coordinates myogenic pumping. Mouse portal vein also expresses a Na ϩ current that can induce myogenic contractions when stimulated with veratridine, although under unstimulated conditions it does not seem to participate in spontaneous activity (29) . Similarly, in rat mesenteric artery, veratridine induced contractions that appeared to be only partly accounted for by neurotransmitter release (13) . Although these vessels consistently expressed Na V 1.2 and Na V 1.3, expression of Na V 1.5, Na V 1.6, or Na V 1.7 was only seen in some tissue samples (13) . Apart from the present study, the only other prominent examples of currents mediated by the Na V 1.5 subtype are found in gastrointestinal muscle, where they are also mechanosensitive (15, 23, 34) . In these tissues, peristalsis occurs as a complex interaction between intrinsic nerves and myogenic contraction. While the role of Na ϩ current in gastrointestinal muscle is unclear, it is interesting that people with pathological mutations of the SCN5A gene suffer from an increased incidence of gastrointestinal symptoms, suggesting a subtle disruption of normal motility (20, 28) . In airway, we have been unable to demonstrate an effect of the Na ϩ current on myogenic contraction, even in the presence of veratridine (Bradley et al., unpublished observations), although we could show prolongation of the action potential in single cells (Fig. 5) . Possibly the reason for a lack of contractile response in tissue strips is that the resting potential in the ASMC in vitro is set at a level where all the Na ϩ current is inactivated and, therefore, unavailable (e.g., Ϫ60 mV) (17) . Even so, this still leaves open the possibility that, under some inflammatory conditions, certain mediators might shift the voltage-dependent inactivation of the current in the positive direction along the voltage axis, so that it becomes available. Therefore, apart from the possibility that the Na ϩ current might be involved in airway remodeling, it is conceivable that, under some pathophysiological conditions, it could contribute to mechanisms underlying bronchospasm. In any case, the presence of such a large voltage-dependent Na ϩ current in bronchial smooth muscle cells should be noted and warrants further attention.
